Neko Health raises $700M Series C led by Lightspeed
Original: Daniel Ek’s body-scanning startup Neko Health raises another $700M
Why This Matters
Neko Health's rapid fundraising signals growing investor confidence in preventive health tech and AI-assisted diagnostics.
Body-scanning startup Neko Health, co-founded by Spotify's Daniel Ek, raised a $700 million Series C led by Lightspeed Venture Partners and O.G. Venture Partners. The round follows a $260M Series B in January 2025. Over 100,000 scans have been completed, with 350,000+ on waitlists.
Neko Health, the health assessment startup co-founded by Spotify CEO Daniel Ek and Hjalmar Nilsonne, has closed a $700 million Series C round. The financing was led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. This follows the company's $260 million Series B raised in January 2025, bringing total fundraising to over $960 million.
Neko Health combines proprietary full-body scanning technology with bloodwork to produce comprehensive health assessments. Recent additions include body composition data for fitness-focused users and integration with Apple Health, giving clinicians real-world patient data. The company currently operates clinics in the U.K. and Sweden and is preparing to open its first U.S. location in New York. More than 100,000 people have received scans, while over 350,000 have joined the waitlist or booked appointments.
Calm co-founder Alex Tew shared on X that a Neko scan detected a malignant mole on his back that was subsequently removed. 'I'm grateful to Neko for helping me discover this,' he wrote. Neko Health faces emerging competition from Midjourney, which is developing its own body scanner planned for a San Francisco spa experience opening in 2027.